Literature DB >> 18483176

Sex-specific early growth hormone response genes in rat liver.

Valerie Wauthier1, David J Waxman.   

Abstract

Pituitary GH-secretory profiles are sex dependent and regulate the sexually dimorphic expression of a large number of genes in the liver. The slow response of many sex-specific liver genes to changes in plasma GH status suggests that GH acts in the liver via both direct and indirect mechanisms organized in a hierarchical regulatory network. Presently, genome-wide liver transcription profiling was conducted to elucidate the global impact of pituitary hormone ablation on the sex specificity of rat liver gene expression and to identify sex-specific genes that respond rapidly to GH as candidates for direct targets of GH action. Hypophysectomy abolished the sex specificity of approximately 90% of 1032 sex-dependent genes, consistent with the dominant role of pituitary GH in regulating liver sexual dimorphism. Two major classes of sex-specific genes were identified: genes that were down-regulated after hypophysectomy and may be subject to positive GH regulation (461 class I genes), and genes that were up-regulated after hypophysectomy and may be subject to negative GH regulation (224 class II genes). Fifty class I sex-specific genes were induced, and 38 class II sex-specific genes were suppressed within 90 min of a physiological GH pulse, suggesting they are primary GH response genes. A further 71 sex-specific genes responded after a second GH treatment and may correspond to secondary response genes. Twenty four DNA-binding proteins were identified as early GH response genes, of which 15 were induced and nine were suppressed by GH. Five of these 24 genes displayed sex-specific expression, consistent with a hierarchical transcriptional network controlling sex-specific liver gene expression. Class II male-specific genes, such as Cyp2a2 and Cyp2c13, were down-regulated within 30 min of GH pulse treatment, as determined by heterogeneous nuclear RNA analysis, suggesting that transcription of these genes is restricted to the GH-free interpulse period in adult male rat liver. We conclude that GH acts via both positive and negative regulatory mechanisms to establish and maintain the sex specificity of liver gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483176      PMCID: PMC2725767          DOI: 10.1210/me.2007-0549

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  53 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver.

Authors:  N Delesque-Touchard; S H Park; D J Waxman
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

3.  DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.

Authors:  E Soldaini; S John; S Moro; J Bollenbacher; U Schindler; W J Leonard
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 4.  Sex and the liver - a journey through five decades.

Authors:  Agneta Mode; Jan-Ake Gustafsson
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

5.  STAT5b-deficient mice are growth hormone pulse-resistant. Role of STAT5b in sex-specific liver p450 expression.

Authors:  H W Davey; S H Park; D R Grattan; M J McLachlan; D J Waxman
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

6.  Intrinsic signals in the sexually dimorphic circulating growth hormone profiles of the rat.

Authors:  A K Agrawal; B H Shapiro
Journal:  Mol Cell Endocrinol       Date:  2001-02-28       Impact factor: 4.102

7.  Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone.

Authors:  O Lahuna; M Rastegar; D Maiter; J P Thissen; F P Lemaigre; G G Rousseau
Journal:  Mol Endocrinol       Date:  2000-02

8.  Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression.

Authors:  H K Choi; D J Waxman
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

9.  Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat.

Authors:  A K Agrawal; B H Shapiro
Journal:  J Pharmacol Exp Ther       Date:  2000-01       Impact factor: 4.030

10.  Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription.

Authors:  D J Waxman; P A Ram; S H Park; H K Choi
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

View more
  36 in total

1.  Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.

Authors:  Guoyu Ling; Aarathi Sugathan; Tali Mazor; Ernest Fraenkel; David J Waxman
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

Review 2.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

3.  Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver.

Authors:  Aarathi Sugathan; David J Waxman
Journal:  Mol Cell Biol       Date:  2013-07-08       Impact factor: 4.272

4.  Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.

Authors:  Tara L Conforto; Yijing Zhang; Jennifer Sherman; David J Waxman
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

5.  Sex-Biased lncRNAs Inversely Correlate With Sex-Opposite Gene Coexpression Networks in Diversity Outbred Mouse Liver.

Authors:  Tisha Melia; David J Waxman
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

6.  The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.

Authors:  Robert M Bigsby; Andrea Caperell-Grant
Journal:  Carcinogenesis       Date:  2011-05-23       Impact factor: 4.944

Review 7.  Gene regulation by growth hormone.

Authors:  Peter Rotwein; Dennis J Chia
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

8.  Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription.

Authors:  Yili Chen; Grace Lin; Jeffrey S Huo; Deborah Barney; Zhenni Wang; Tamara Livshiz; David J States; Zhaohui S Qin; Jessica Schwartz
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

Review 9.  Regulation of gene expression by growth hormone.

Authors:  Peter Rotwein
Journal:  Mol Cell Endocrinol       Date:  2020-03-06       Impact factor: 4.102

10.  RNA profiles of rat olfactory epithelia: individual and age related variations.

Authors:  Maud Rimbault; Stéphanie Robin; Amaury Vaysse; Francis Galibert
Journal:  BMC Genomics       Date:  2009-12-02       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.